<i>Retracted:</i> Dual targeting of <scp>RANKL</scp> and <scp>PD</scp> ‐1 with a bispecific antibody improves anti‐tumor immunity

William C. Dougall, Amelia Roman Aguilera, Mark J. Smyth

DOI: 10.1002/cti2.1081
Published: 2019-01
Container: Clinical & Translational Immunology
Publisher: Wiley
Open access: unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/cti2.1081,
  title = {<i>Retracted:</i>
                    Dual targeting of
                    <scp>RANKL</scp>
                    and
                    <scp>PD</scp>
                    ‐1 with a bispecific antibody improves anti‐tumor immunity},
  author = {William C. Dougall and Amelia Roman Aguilera and Mark J. Smyth},
  year = {2019},
  journal = {Clinical \&amp; Translational Immunology},
  doi = {10.1002/cti2.1081},
  url = {https://doi.org/10.1002/cti2.1081}
}

RIS

TY  - JOUR
TI  - <i>Retracted:</i>
                    Dual targeting of
                    <scp>RANKL</scp>
                    and
                    <scp>PD</scp>
                    ‐1 with a bispecific antibody improves anti‐tumor immunity
AU  - William C. Dougall
AU  - Amelia Roman Aguilera
AU  - Mark J. Smyth
PY  - 2019
JO  - Clinical &amp; Translational Immunology
DO  - 10.1002/cti2.1081
UR  - https://doi.org/10.1002/cti2.1081
ER  -

APA

Dougall, W. C., Aguilera, A. R., & Smyth, M. J. (2019). <i>Retracted:</i> Dual targeting of <scp>RANKL</scp> and <scp>PD</scp> ‐1 with a bispecific antibody improves anti‐tumor immunity. Clinical & Translational Immunology. https://doi.org/10.1002/cti2.1081

Source records

crossref · retrieved 2026-09-25T04:25:28.502Z